UK markets closed

Viking Therapeutics, Inc. (VKTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
74.74-2.23 (-2.90%)
As of 01:23PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-93,720
-85,895
-68,867
-54,990
-39,495
Depreciation & amortisation
294
292
291
296
277
Stock-based compensation
21,162
16,750
8,673
6,100
5,818
Change in working capital
27,903
3,548
10,189
-2,927
7,717
Accounts payable
1,427
-1,018
7,085
-2,544
1,555
Other working capital
-54,867
-73,376
-48,397
-47,586
-21,777
Other non-cash items
128
131
100
29
138
Net cash provided by operating activities
-54,867
-73,376
-48,397
-47,586
-21,777
Cash flows from investing activities
Purchases of investments
-1,017,509
-478,303
-121,431
-168,015
-280,636
Sales/maturities of investments
376,433
299,217
176,184
205,975
322,203
Net cash used for investing activities
-641,076
-179,086
54,753
37,960
41,567
Cash flows from financing activities
Common stock repurchased
-
0
-6,795
0
-
Other financing activities
268,910
264,608
10,110
-753
-322
Net cash used provided by (used for) financing activities
873,229
271,376
4,163
6,880
950
Net change in cash
177,286
18,914
10,519
-2,746
20,740
Cash at beginning of period
18,362
36,632
26,371
29,117
8,377
Cash at end of period
195,648
55,516
36,632
26,371
29,117
Free cash flow
Operating cash flow
-54,867
-73,376
-48,397
-47,586
-21,777
Free cash flow
-54,867
-73,376
-48,397
-47,586
-21,777